DEBATING FACTS vs Compensated Journalists = Waste of Time
it is not worth debating or discussing the facts with those creative and compensated journalists.
They will continue to misguide and misinform unknowing investors, regardless of what facts are stated to prove their claims incorrect, regardless of how many times they are repeated.
My father use to say, "Never argue with an idiot or someone trying to screw you out of your money. Both belong in one institution or the other."
Moving forward, there is no reason to debate or argue with said parties. All of the facts have been posted on this board and on a number of the boards targeted by the pump first and distort second groups.
Investors and shareholders are encouraged to educate themselves on the truth regarding the daily short volume numbers, and the loopholes by which market makers avoid reporting their short interest (legal or illegal), to FINRA, so the investment public can't see how massive their counterfeiting electronic equity empire is.
The other tool being used to twist the facts are the daily buys vs sells data.
The bid is what buyers are willing to pay for a stock or security and the Ask is what they are willing to sell it for. Period!
I wonder if one of the creative journalist can explain *WHY* trades that go off at the bid are recorded as sells and trades that go off at the ask are recorded as buys?
I doubt they can! There is only one justified explanation for it, and it is somewhat counterintuitive to what a bid and an ask truly is.
The facts have all been posted ad nauseum, yet those trying to misinform continue to stick with their script.
It will be interesting to watch as the script continues to evolve to support their agenda and support their attempts to mislead investors.
The more educated we have become as investors, the more obvious the agenda has become. At the same time, the more frustrated many of us have become.
Those short selling and naked short selling and using resources to *assist* in their unlawful gains will be on the FBI, DOJ and DHS radar once the powers that be decide it is time for growth and expansion in the global economy again.
Until then, there are other ways to fight the good fight without debating endlessly with anonymous aliases who are protected by interested parties.
(posted by SevenTenEleven October 22, 2012)
DEBATING FACTS vs Compensated Journalists = Waste of Time
Top 10 Most Recent News Articles
First Industrial Declares Regular Dividend Amid Growth Insights
Dividend Declaration Reflects Confidence First Industrial Realty Trust, folks, just put another office stamp on their ongoing reliability quest—and I'm talking dividends. They're shelling out a tidy $0.50 per share for Q4 2026, with stockholders due to see the cash on January 19, 2027. That's like clockwork precision, showing a steadiness in what some call the unruly...
Continue Reading
Trimble's Q3 2026: Guidance Update and Record ARR
Trimble Smashes Through Q3 Expectations Trimble Inc. (NASDAQ:TRMB) tossed a bit of a curveball by posting Q3 2026 results that sailed past analyst forecasts. We’re talking revenue swelling to $966.8 million, a decent 7% bump from the previous year. Now, for a company riding its 'Connect & Scale' strategy, this serves as a validation of its aggressive scaling ambitions....
Continue Reading
Fractal Sees Explosive Q2 Gain: Revenue Hits $100M
Fractal’s Revenue Moment: Climbing New Peaks Fractal Analytics just knocked it out of the park, folks. Imagine this—an AI company pulling in $100 million for the first quarter, getting a 20% jump in revenue year on year. That's right, these numbers aren't just fancy figures; they're staggering proof that Fractal's hitting its AI stride. The healthcare and life...
Continue Reading
Zuellig Pharma Expands Clinical Capabilities in China
Zuellig Pharma's Strategic Leap in Hangzhou You know, in the ever-evolving world of biotech and pharmaceuticals, setting up shop in the right locale can mean the difference between breakthroughs and breakdowns. So Zuellig Pharma—a major player, but not exactly a household ticker—made a smart move acquiring a clinical facility in Hangzhou. This is no minor shuffle;...
Continue Reading
Natixis' $100M Student Challenge Mixes Real Stakes
Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...
Continue Reading
VAB's Pharma Ad Guide: Emerging Trends and Insights
Pharma's not just popping pills anymore; it's a whole show on multiscreen TV. The Video Advertising Bureau (VAB) just dropped a bombshell of a guide called The Pharmacy, diving into the state of pharmaceutical direct-to-consumer (DTC) advertising. Over the past year and a half, VAB's been grilling agencies, media folks, and anyone else with skin in the game to sketch the...
Continue Reading
Coretek Joins CRN's Elite AI Innovators of 2026
Coretek's Leap to AI Innovator Status Here we are, folks. Another announcement hits the wires that showcases a company's ascent amid the swelling AI tide. Coretek, hailing from Farmington Hills, managed to snag a spot on CRN's inaugural 2026 AI Innovators list. No small potatoes, if you ask me, considering the competition on this playing field. Why the fuss? It's about...
Continue Reading
Allego Dominates 2026 Gartner Magic Quadrant: Why It Matters
Allego Secures Top Spot Yet Again I've seen companies rise and fall on the whims of industry recognition, and let me tell ya, Allego's riding high on the right wave. For the second year running, this outfit's been named a Leader in the 2026 Gartner Magic Quadrant for Revenue Enablement Platforms. Recognized for its Completeness of Vision—yeah, that's no small feat...
Continue Reading
KOVE's Bold Lineup Expansion at EICMA 2026
What's Roaring: The Latest from KOVE Anybody who’s been following motorcycle trends knows that EICMA 2026 was destined to be a spectacle, and KOVE didn’t disappoint. They rolled out a fleet of five new models, including the 125 RALLY, 350 RALLY, 650RR, and two head-turners on the electric front: the BONIC and the E-500RR. Each model brings something fresh to the...
Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships
Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...
Continue ReadingTop 5 Most Recently Viewed Articles
Tesla's Earnings Impact: A Preview for Investors Ahead
Tesla's Earnings and Market Dynamics As we gear up for Tesla's earnings announcement, all eyes are turning to the electric vehicle giant (NASDAQ: TSLA). Tesla is leading the charge as the first among the prominent group of tech companies known as the "Magnificent Seven" to reveal its financial performance. The anticipation builds as markets reflect on how business...
Continue Reading
Atos Group Releases Detailed Half-Year Financial Report for 2025
Atos Group Updates on Financial Performance for 2025 Availability of the 2025 Half-year Financial Report Atos Group has made significant strides in its financial reporting for 2025, announcing the release of its half-year financial report. This document was published on the Atos website and was also filed with the French Financial Markets Authority (AMF). Insights from...
Continue Reading
Anywhere Real Estate and Canva Team Up for Agents' Success
Anywhere Real Estate's Exciting New Partnership Anywhere Real Estate Inc. (NYSE: HOUS), a global frontrunner in the residential real estate sector, has recently unveiled an impactful collaboration with Canva, a recognized visual communication platform. This agreement aims to empower Every agent within their extensive network. Enhanced Tools for Affiliated Agents This...
Continue Reading
THEON Showcases Innovative A.R.M.E.D. Ecosystem at IDEX 2025
THEON Unveils Revolutionary A.R.M.E.D. Ecosystem At IDEX 2025, THEON made a significant impact by showcasing its A.R.M.E.D. (Augmented Reality Modular Ecosystem of Devices), designed to elevate the capabilities of tomorrow's soldiers. This integrated solution promises to improve tactical awareness, effectiveness, and survivability for modern combat operatives....
Continue Reading
Exploring Advances in Arthrogryposis at Montreal Symposium
4th International Symposium on Arthrogryposis Unveiled in Montreal MONTREAL — The Shriners Hospitals for Children - Canada is set to host the much-anticipated 4th International Symposium on Arthrogryposis from September 28 to October 1. This initiative brings together renowned healthcare professionals and researchers from various pediatric centers in Montreal,...
Continue Reading